Ambio, Inc.
Rob Hughes is currently employed as the CFO at STRM.BIO, Basking Biosciences Inc, and Ambio, Inc. Rob has extensive experience in finance and administration roles within venture capital-backed biotech and pharmaceutical startups. Prior to their current positions, Rob served as the Executive Vice President of Finance and Administration at StrideBio, Inc, and as the Senior Vice President of Finance at Selenity Therapeutics. Rob also held various finance positions at Viamet Pharmaceuticals, KBI BioPharma, and HMS Host. Rob holds an MBA from UNC Kenan-Flagler Business School and a degree in Accounting & Finance from the University of Maryland.
This person is not in any teams
Ambio, Inc.
Ambio is a specialty pharmaceutical company developing biosimilar, bioequivalent, and other complex generic drugs, with expertise in peptide drug development.